Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119222135 | 11922213 | 5 | F | 20160812 | 20160115 | 20160817 | EXP | CA-PFIZER INC-2016017452 | PFIZER | 64.00 | YR | F | Y | 0.00000 | 20160817 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119222135 | 11922213 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | 0 | ||||||||||
| 119222135 | 11922213 | 2 | PS | CELEBREX | CELECOXIB | 1 | Oral | UNK | 20998 | CAPSULE, HARD | |||||||||
| 119222135 | 11922213 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | UNK | 7073 | ||||||||||
| 119222135 | 11922213 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | UNK, WEEKLY | 11719 | 20 | MG | SOLUTION FOR INJECTION | /wk | ||||||
| 119222135 | 11922213 | 5 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 6 | SS | ARAVA | LEFLUNOMIDE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 119222135 | 11922213 | 7 | SS | ACTONEL | RISEDRONATE SODIUM | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 9 | SS | ORENCIA | ABATACEPT | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 10 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 11 | SS | SIMPONI | GOLIMUMAB | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 12 | SS | PROLIA | DENOSUMAB | 1 | UNK | 0 | |||||||||||
| 119222135 | 11922213 | 13 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD | |||||||
| 119222135 | 11922213 | 14 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119222135 | 11922213 | 1 | Rheumatoid arthritis |
| 119222135 | 11922213 | 2 | Rheumatoid arthritis |
| 119222135 | 11922213 | 3 | Rheumatoid arthritis |
| 119222135 | 11922213 | 4 | Rheumatoid arthritis |
| 119222135 | 11922213 | 5 | Rheumatoid arthritis |
| 119222135 | 11922213 | 6 | Rheumatoid arthritis |
| 119222135 | 11922213 | 7 | Rheumatoid arthritis |
| 119222135 | 11922213 | 8 | Rheumatoid arthritis |
| 119222135 | 11922213 | 9 | Rheumatoid arthritis |
| 119222135 | 11922213 | 10 | Rheumatoid arthritis |
| 119222135 | 11922213 | 11 | Rheumatoid arthritis |
| 119222135 | 11922213 | 12 | Rheumatoid arthritis |
| 119222135 | 11922213 | 14 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119222135 | 11922213 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119222135 | 11922213 | Condition aggravated | |
| 119222135 | 11922213 | Drug ineffective | |
| 119222135 | 11922213 | Foot fracture | |
| 119222135 | 11922213 | Lower limb fracture | |
| 119222135 | 11922213 | Osteoporosis | |
| 119222135 | 11922213 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119222135 | 11922213 | 4 | 20121104 | 0 | ||
| 119222135 | 11922213 | 5 | 201408 | 201602 | 0 | |
| 119222135 | 11922213 | 6 | 20121104 | 20141206 | 0 | |
| 119222135 | 11922213 | 13 | 20121104 | 20141206 | 0 | |
| 119222135 | 11922213 | 14 | 20160315 | 0 |